Advance quickly to clinical trials
You need to quickly build processes, validate lead candidates and delivery systems, and scale for launch. Cytiva’s process development services—covering plasmid DNA (pDNA), messenger RNA (mRNA), and lipid nanoparticles (LNPs)—are designed to help you do just that.
How we can help with nucleic acid process development
Experience full support across your workflows
Process development and scale-up
for pDNA and mRNA
Formulation screening and development
Analytical and bioassay services
Tech transfer and manufacturing
Flexible scale and scope
Whether you’re looking for a small study, in-process assays, or an end-to-end process – we define project scope based on your needs. After the project ends, you can bring your process in-house, use your own CDMO, or work with Aldevron. You can also choose our CDMO for:
- pDNA fermentation: 50 mL to 50 L; inquire about 200 L
- mRNA IVT: 300 mL; inquire about 1000 mL
Nucleic acid process development success stories
Fast-track to GMP
Replicate Bioscience collaborated with Cytiva to accelerate their self-replicating RNA vaccine program, achieving GMP manufacturing and IND filing within 18 months.Rapid mRNA scale-up
COVID-19 programs scaled mRNA processes in less than eight weeks.FDA-ready workflows
Advanced mRNA services enabled FDA trial approvals through optimized IVT, purification, and analytics.Take related training courses
Gain useful skills and know-how through hands-on and virtual courses led by instructors with industry expertise. Topics include: